Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Serious Games

Date Submitted: May 20, 2024
Date Accepted: Nov 19, 2024

The final, peer-reviewed published version of this preprint can be found here:

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial

Bloomfield L, Boston J, Masek M, Andrew L, Barwood D, Devine A

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial

JMIR Serious Games 2025;13:e60755

DOI: 10.2196/60755

PMID: 39932769

PMCID: 11862768

Evaluating the efficacy of a serious game to deliver health education about invasive meningococcal disease using a clustered randomised controlled equivalence trial

  • Lauren Bloomfield; 
  • Julie Boston; 
  • Martin Masek; 
  • Lesley Andrew; 
  • Donna Barwood; 
  • Amanda Devine

ABSTRACT

Background:

Invasive Meningococcal disease (IMD) is a serious, vaccine-preventable infectious disease that can be life threatening.

Objective:

To evaluate the efficacy of Meningococcal Immunisation Awareness, Prevention and Protection app (MIApp), a serious game to deliver health education about IMD to adolescents.

Methods:

A clustered, randomised controlled equivalence trial involving students (Years 7-10) from six secondary schools across metropolitan Western Australia completed a pre-and post-intervention questionnaire with a follow-up at three months post-intervention to measure the primary outcome of IMD knowledge acquisition following this self-guided intervention. The findings were compared to changes in an active control (comparison) group that received an in-class educational presentation about IMD transmission and protection. Median scores for knowledge pre- and post-intervention were collected from a self-administered assessment (Qualtrics), and at three months post-intervention, they were compared between groups. A knowledge score of +/- 2/16 was determined a priori to meet the criteria for equivalence.

Results:

Of the 788 participating students, the median post-intervention correct score in both the MIApp and control cohorts was 14/16 (87.5% correct responses), compared to the median pre-intervention correct score of 6/16 (37.5% correct responses) representing a significant (p<0.01) increase in IMD knowledge in both groups. Improvements were retained in both groups three months after the initial intervention (median correct score 11/16 intervention, 12/16 control, p=0.86) demonstrating the efficacy of MIApp to deliver health education about IMD transmission and protection, although response rates in the follow-up cohort were low (11.3%).

Conclusions:

Participating adolescents considered the MIApp game more enjoyable than a presentation, with equivalent improvements in knowledge. Serious games could represent a constructive tool to help teachers impart specialised health education. Clinical Trial: Not applicable


 Citation

Please cite as:

Bloomfield L, Boston J, Masek M, Andrew L, Barwood D, Devine A

Evaluating the Efficacy of a Serious Game to Deliver Health Education About Invasive Meningococcal Disease: Clustered Randomized Controlled Equivalence Trial

JMIR Serious Games 2025;13:e60755

DOI: 10.2196/60755

PMID: 39932769

PMCID: 11862768

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.